Erratum: Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells (International Journal of Molecular Medicine (2012) 29 (607-612) DOI: 10.3892/ijmm.2012.884);Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells

International Journal of Molecular Medicine

Volumn 29, Issue 4, 2012, Pages 607-612

  Du, Jian ^a   Tang, Bo ^a   Wang, Jingwen ^b   Sui, Hongtao ^a   Jin, Xueli ^a   Wang, Liming ^a   Wang, Zhongyu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Alpinetin; Apoptosis; Caspases; Cell cycle; Pancreatic cancer; Proliferation

Indexed keywords

ALPINETIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

EID: 84863274528     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2023.5303     Document Type: Erratum

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007. (Pubitemid 46148091)
2. Lockhart AC, Rothenberg ML and Berlin JD: Treatment for pancreatic cancer: current therapy and continued progress. Gastroenterology 128: 1642-1654, 2005. (Pubitemid 40692557)
3. Wray CJ, Ahmad SA, Matthews JB and Lowy AM: Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128: 1626-1641, 2005. (Pubitemid 40692556)
4. Gudjonsson B: Pancreatic cancer: survival errors and evidence. Eur J Gastroenterol Hepatol 21: 1379-1382, 2009.
5. Fulda S: Tumor resistance to apoptosis. Int J Cancer 124: 511-515, 2009.
6. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
7. Vogel S, Ohmayer S, Brunner G and Heilmann J: Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg Med Chem 16: 4286-4293, 2008. (Pubitemid 351539046)
8. Tang J, Li N, Dai H and Wang K: Chemical constituents from seeds of Alpinia katsumadai, inhibition on NF-kappaB activation and antitumor effect. Zhongguo Zhong Yao Za Zhi 35: 1710-1714, 2010 (In Chinese).
9. Wang S, Zhou L, He W and Hu Z: Separation and determination of alpinetin and cardamonin by reverse micelle electrokinetic capillary chromatography. J Pharm Biomed Anal 43: 1557-1561, 2007. (Pubitemid 46282395)
10. He W, Li Y, Tang J, Luan F, Jin J and Hu Z: Comparison of the characterization on binding of alpinetin and cardamonin to lysozyme by spectroscopic methods. Int J Biol Macromol 39: 165-173, 2006. (Pubitemid 44602201)
11. Malek SN, Phang CW, Ibrahim H, Norhanom AW and Sim KS: Phytochemical and cytotoxic investigations of Alpinia mutica rhizomes. Molecules 16: 583-589, 2011.
12. In LL, Azmi MN, Ibrahim H, Awang K and Nagoor NH: 1′S-1′- acetoxyeugenol acetate: a novel phenylpropanoid from Alpinia conchigera enhances the apoptotic effects of paclitaxel in MCF-7 cells through NF-κB inactivation. Anticancer Drugs 22: 424-434, 2011.
13. He ZH, Ge W, Yue GG, Lau CB, He MF and But PP: Anti-angiogenic effects of the fruit of Alpinia oxyphylla. J Ethnopharmacol 132: 443-449, 2010.
14. Hamacher R, Schmid RM, Saur D and Schneider G: Apoptotic pathways in pancreatic ductal adenocarcinoma. Mol Cancer 7: 64, 2008.
15. Cui J, Sun R, Yu Y, Gou S, Zhao G and Wang C: Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother Res 24: 1637-1644, 2010.
16. Shoji K, Tsubaki M, Yamazoe Y, Satou T, Itoh T, Kidera Y, Tanimori Y, Yanae M, Matsuda H, Taga A, et al: Mangiferin induces apoptosis by suppressing Bcl-xL and XIAP expressions and nuclear entry of NF-κB in HL-60 cells. Arch Pharm Res 34: 469-475, 2011.
17. Köhler C, Orrenius S and Zhivotovsky B: Evaluation of caspase activity in apoptotic cells. J Immunol Methods 265: 97-110, 2002. (Pubitemid 34628806)
18. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H amd Wang L: Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28: 1077-1085, 2011.
19. Arlt A, Müerköster SS and Schäfer H: Targeting apoptosis pathways in pancreatic cancer. Cancer Lett: Nov 13, 2010 (Epub ahead of print).
20. Burlacu A: Regulation of apoptosis by bcl-2 family proteins. J Cell Mol Med 7: 249-257, 2003.
21. Cory S and Adams JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002. (Pubitemid 37328916)
22. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR and Newmeyer DD: Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mito-chondrial membrane. Cell 111: 331-342, 2002. (Pubitemid 35341388)
23. Cheng EH, Levine B, Boise LH, Thompson CB and Hardwick JM: Bax-independent inhibition of apoptosis by Bcl-xL. Nature 379: 554-556, 1996.
24. Yin XM, Oltvai ZN and Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369: 321-323, 1994. (Pubitemid 24159542)
25. Wong HH and Lemoine NR: Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 6: 412-422, 2009.
26. Fulda S: Apoptosis pathways and their therapeutic exploitation in pancreatic cancer. J Cell Mol Med 13: 1221-1227, 2009.
27. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
28. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387: 773-776, 1997.
29. Riedl SJ and Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907, 2004. (Pubitemid 39486541)
30. Chen M and Wang J: Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-319, 2002. (Pubitemid 34832255)
31. Chien SY, Wu YC, Chung JG, Yang JS, Lu HF, Tsou MF, Wood WG, Kuo SJ and Chen DR: Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells. Hum Exp Toxicol 28: 493-503, 2009.